Randal J. Kirk logo

Randal J. Kirk

Description

R.J. Kirk is Chairman and Chief Executive Officer of Intrexon, a leading synthetic biology technology company. Mr. Kirk was named Chairman ...

Investor Profile

Randal J. Kirk has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series F, Series E, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science, Medical.

Stage Focus

  • Series F (33%)
  • Series E (33%)
  • Post Ipo Equity (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Randal J. Kirk frequently co-invest with?

Third Security
North America, Virginia, United States, Radford
Co-Investments: 2
NC
North America, Virginia, United States, Radford
Co-Investments: 1

Which angels does Randal J. Kirk often collaborate with?

BM
North America, Maryland, United States, Baltimore
Shared Deals: 1

What are some of recent deals done by Randal J. Kirk?

Precigen

Germantown, Maryland, United States

Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.

BiotechnologyLife ScienceMedicalTherapeutics
Post Ipo EquityDec 27, 2024
Amount Raised: $79,000,000
Precigen

Germantown, Maryland, United States

Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.

BiotechnologyLife ScienceMedicalTherapeutics
Series FMay 2, 2013
Amount Raised: $150,000,000
Precigen

Germantown, Maryland, United States

Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.

BiotechnologyLife ScienceMedicalTherapeutics
Series EMay 31, 2011
Amount Raised: $100,000,000

Find More Investors Like Randal J. Kirk

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Randal J. Kirk | Pipeseed